Outpace Bio Stock
Outpace Bio is a biotechnology company leveraging AI-powered protein design and synthetic biology to create advanced cell therapies aimed at treating solid tumors.
Founded: 2020
For more Outpace Bio stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Marc Lajoie, PhD Co-Founder and Chief Executive Officer |
| Scott Boyken, PhD Co-Founder and Chief Technology Officer |
| Aaron Foster, PhD Chief Scientific Officer |
| Charity Scripture Chief Development Officer |
| Eric Soller, PhD Chief Business Officer |
